Certified Global Research Member

Key Questions Answered

Global Market Outlook
In-depth analysis of global and regional trends
Analyze and identify the major players in the market, their market share, key developments, etc.
To understand the capability of the major players based on products offered, financials, and strategies.
Identify disrupting products, companies, and trends.
To identify opportunities in the market.
Analyze the key challenges in the market.
Analyze the regional penetration of players, products, and services in the market.
Comparison of major playersâ€™ financial performance.
Evaluate strategies adopted by major players.
Recommendations

Why Choose Market Research Future?

Vigorous research methodologies for specific market.
Knowledge partners across the globe
Large network of partner consultants.
Ever-increasing/ Escalating data base with quarterly monitoring of various markets
Trusted by fortune 500 companies/startups/ universities/organizations
Large database of 5000+ markets reports.
Effective and prompt pre- and post-sales support.

US Nucleic Acid Therapeutics Companies

Companies in the United States specializing in nucleic acid therapeutics focus on developing and commercializing therapies based on nucleic acids, including RNA and DNA, for treating various diseases. These therapeutics have gained attention for their potential in addressing genetic disorders, infectious diseases, and various types of cancers.

US nucleic acid therapeutics Key Companies

Latest US Nucleic Acid Therapeutics Companies Update

Alnylam snaps up Akcea Therapeutics $5.3 billion acquisition in December 2023 strengthens Alnylam's leadership in RNA interference (RNAi) therapies, expanding their pipeline with Akcea's innovative drugs like Onpattro for hereditary ATTR amyloidosis.

Moderna partners with Vertex for cystic fibrosis In a bold collaboration, these two giants join forces to develop mRNA therapies for cystic fibrosis, leveraging Moderna's platform and Vertex's deep understanding of the disease.

Arrowhead Pharmaceuticals' ARO-AAT reaches Phase 3 for alpha-1 antitrypsin deficiency potential breakthrough therapy utilizing RNAi technology progresses towards larger-scale trials, offering hope for patients with this rare genetic condition.

Wave Life Sciences' SPLINTER trial yields positive Phase 1b results for Duchenne muscular dystrophy encouraging early data paves the way for further development of their exon skipping therapy, potentially improving muscle function and mobility for DMD patients.

List of US Nucleic Acid Therapeutics Key Companies in the Market

Benitec Biopharma

Sarpeta Therapeutics

NOVARTIS AG.

Agilent Technologies

Protagonist Therapeutics

Qaigen NV

Genzyme Sanofi

Thermo Fisher Scientific

Copernicus

Arbutus Biopharma

Merck KGaA

Silence Therapeutics

US Nucleic Acid Therapeutics Companies

Leading companies partner with us for data-driven Insights

Kindly complete the form below to receive a free sample of this Report

Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
	Single User	$ 4,950
	Multiuser License	$ 5,950
	Enterprise User	$ 7,250
Compare Licenses

Tailored for You

Dedicated Research on any specifics segment or region.
Focused Research on specific players in the market.
Custom Report based only on your requirements.
Flexibility to add or subtract any chapter in the study.
Historic data from 2014 and forecasts outlook till 2040.
Flexibility of providing data/insights in formats (PDF, PPT, Excel).
Provide cross segmentation in applicable scenario/markets.